Lung transplantation presents very specific challenges, but the most daunting is a form of rejection called bronchiolitis obliterans syndrome (BOS). Doctors know very little about BOS or why recipients are highly susceptible to it. Currently, there are no effective treatments for BOS and lung transplant rejection.
On June 22, 2022, the Lung Transplant Foundation hosted a Bronchiolitis Obliterans Syndrome Externally-led Patient Focused Drug Development virtual meeting.
We began as a small foundation, but we have steadily grown to become a nationally recognized advocate for lung transplant research.
While doctors and researchers have made great strides in the past 50 years, we still have a long way to go. In order to make new scientific breakthroughs possible, we need your help to fund research.
Please consider making a gift to support Lung Transplant Foundation research and patient support programs.
Disclaimer: This website does not provide medical advice. The information, including but not limited to text, graphics, images, and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment before undertaking any new health care regimen. Never disregard any professional medical advice or delay in seeking care because of something you have read on this website.